Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-084920
Filing Date
2024-04-02
Accepted
2024-04-02 17:19:16
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B3 d808285d424b3.htm 424B3 2418594
2 GRAPHIC g808285g17d40.jpg GRAPHIC 635043
3 GRAPHIC g808285g21z01.jpg GRAPHIC 229990
4 GRAPHIC g808285g22z20.jpg GRAPHIC 111814
5 GRAPHIC g808285g23a44.jpg GRAPHIC 78776
6 GRAPHIC g808285g24a45.jpg GRAPHIC 60379
7 GRAPHIC g808285g25i49.jpg GRAPHIC 159213
8 GRAPHIC g808285g47a45.jpg GRAPHIC 76949
9 GRAPHIC g808285g47y28.jpg GRAPHIC 73155
10 GRAPHIC g808285g55g10.jpg GRAPHIC 91735
11 GRAPHIC g808285g71k47.jpg GRAPHIC 159519
12 GRAPHIC g808285g74p91.jpg GRAPHIC 117533
13 GRAPHIC g808285g76i01.jpg GRAPHIC 139907
14 GRAPHIC g808285g85v30.jpg GRAPHIC 65863
15 GRAPHIC g808285g89v99.jpg GRAPHIC 74617
16 GRAPHIC g808285g94y68.jpg GRAPHIC 92145
17 GRAPHIC g808285g99n65.jpg GRAPHIC 163186
  Complete submission text file 0001193125-24-084920.txt   5561709
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268603 | Film No.: 24815620
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)